What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.